Last updated: March 9, 2026
What Is the Scope of DK3740475?
DK3740475 pertains to a pharmaceutical composition, method of use, or process related to a specific therapeutic area. As per patent filings, it centers on a novel aspect of drug formulation or delivery, potentially involving specific molecules, combinations, or administration techniques.
The patent's claims are tailored to protect:
- New chemical entities or derivatives
- Novel formulations or dosage forms
- Methodologies for treating certain medical conditions
- Specific manufacturing processes
Without access to the exact claims text, the scope generally covers innovations aimed at enhancing therapeutic efficacy, stability, or patient compliance.
What Are the Key Claims of DK3740475?
Patent claims define the scope of legal protection. Typically, DK3740475 consists of multiple claims categorized as independent and dependent:
-
Independent Claims: Outline the core invention, such as a new compound or formulation. They specify the structural features, concentration ranges, or combinations that distinguish the invention from prior art.
-
Dependent Claims: Narrow the scope, incorporating additional features like specific excipients, delivery methods, or treatment modalities.
For example, a typical claim might cover:
- "A pharmaceutical composition comprising a compound of formula X and a pharmaceutically acceptable carrier."
- "A method of treating [specific disease], involving administering a therapeutically effective amount of compound X."
The claims likely specify certain parameters—such as dosage, pH range, or stability attributes—that delineate the invention’s boundary.
Patent Landscape of Denmark and International Context
National Patent Environment
Denmark’s patent law aligns with European standards, offering robust protection for pharmaceuticals. The Danish Patent and Trademark Office (DKPTO) grants patents with a maximum term of 20 years from the application date, subject to fee payments.
European Patent Considerations
DK3740475 may be part of a broader European patent family, filed through the European Patent Office (EPO). European patents can be validated in Denmark, providing enforceable rights within the country.
International Patent Protection
For broader market coverage, patent owners typically pursue Patent Cooperation Treaty (PCT) applications, expanding protection across multiple jurisdictions. The timing of national phase entries influences the ability to enforce patent rights globally.
Patent Family and Related Applications
The patent family for DK3740475 includes:
- Priority applications, possibly filed in other jurisdictions
- Family members filed in the U.S., EP, and PCT databases
- Continuation or divisional applications targeting specific claims or embodiments
Reviewing these provides insights into the geographical strategy and potential strength of patent protection.
Patent Validity and Challenges
Patent validity can face challenges based on prior art, inventive step, or novelty. Key factors include:
- Examination reports from DKPTO or EPO
- Opposition proceedings in jurisdictions with opposition periods
- Litigation history, if any, indicating enforceability
Patent Landscape Analysis: Competitive and Innovation Trends
Major Players
The patent landscape likely involves:
- The applicant filing DK3740475
- Other companies/NKAs pursuing similar compounds or formulations
- Universities or research institutions in Denmark and Europe contributing to R&D
Overlapping Patents and Freedom to Operate
Overlap exists with patents covering:
- Similar chemical classes
- Alternative therapeutic approaches
- Different formulations of the same active ingredient
A freedom-to-operate (FTO) analysis is essential to determine if DK3740475 or related patents could face infringement issues.
Patent Citations and Influences
Patent citations, both backward (to prior art) and forward (by subsequent filings), reveal:
- The technological foundation of the invention
- Innovation trends within the therapeutic area
- Key inventive milestones
Citations from international databases like Espacenet or PATENTSCOPE can detail these connections.
Patent Expiry and Life Cycle
Standard patent term is 20 years from priority date, with possible extensions or adjustments. The expiration date influences:
- Competitive landscape
- Generic development opportunities
- Life cycle management strategies
Summary of Key Data
| Aspect |
Details |
| Patent number |
DK3740475 |
| Filing date |
[Unknown — verify via DKPTO database] |
| Priority date |
[Likely prior to DK filing] |
| Expiry date |
Approximately [20 years after filing] |
| Inventors/Public contact |
[Typically disclosed in patent document] |
| Patent family members |
To be confirmed via EPO or PCT databases |
| Core claim focus |
[Chemical composition, method, formulation] |
Conclusion
DK3740475 has a scope primarily centered on specific drug formulations or therapeutic methods, with protection boundaries defined by precise structural or procedural claims. Its landscape interacts with broader European and international patent strategies, with potential overlaps and validity considerations. The patent’s strength depends on claims scope, prior art references, and ongoing legal challenges.
Key Takeaways
- The patent covers a specific pharmaceutical innovation, likely with detailed claims on composition or use.
- Its enforceability hinges on claim novelty, inventive step, and absence of prior-art conflicts.
- Filing strategies involve Danish national, European, and PCT routes, emphasizing regional and global protections.
- Overlapping patents and FTO analysis are critical for assessing commercialization risks.
- Patent lifecycle status will influence competitive positioning and market opportunity.
FAQs
1. How can I verify the exact claims of DK3740475?
Access the DKPTO public register or EPO's Espacenet database to review the full patent document.
2. Does DK3740475 protect a new chemical entity?
Likely yes, if the claims specify a novel compound structure; confirmation requires reading the claims.
3. Can DK3740475 be enforced in other countries?
Protection is limited to Denmark unless extended via European or PCT applications.
4. When does DK3740475 expire?
Typically 20 years from the filing date, unless extended or challenged; verify based on specific filing and priority dates.
5. Are there known legal challenges or oppositions to this patent?
Review patent opposition records in DKPTO and EPO for formal challenge histories.
References
- European Patent Office. (2023). EP patent application and family data. Retrieved from https://worldwide.espacenet.com
- Danish Patent and Trademark Office. (2023). Patent database. Retrieved from https://danishpatentandtrademarkoffice.dk
- World Intellectual Property Organization. (2023). PCT Applications. Retrieved from https://www.wipo.int/pct/en
